Jean Doyen
Overview
Explore the profile of Jean Doyen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Latsuzbaia A, Van Keer S, Broeck D, Weyers S, Donders G, De Sutter P, et al.
J Med Virol
. 2025 Mar;
97(3):e70273.
PMID: 40028694
In this report, the clinical performance of Liferiver HarmoniaHPV and Liferiver VenusHPV was evaluated under the VALHUDES framework. Five hundred and twenty-three women collected first-void urine (FVU) with Colli-Pee and...
2.
Van Keer S, Teblick L, Donders G, Weyers S, Doyen J, Cornelis A, et al.
J Med Virol
. 2025 Feb;
97(2):e70254.
PMID: 39981930
Urine-based self-sampling approaches can simplify cervical screening programs whilst increasing response. This study reports on the performance of Abbott Alinity m HR HPV on urine, self-collected at home using a...
3.
Hendrickx J, Van Keer S, Donders G, Weyers S, Doyen J, Beyers K, et al.
Arch Public Health
. 2025 Feb;
83(1):32.
PMID: 39934916
Background: Cervical cancer (CC) is the fourth most common cancer globally in females, caused by oncogenic infections with high-risk human papillomavirus (hrHPV) strains. Successful CC screening programs strongly depend on...
4.
Latsuzbaia A, Van Keer S, Broeck D, Weyers S, Donders G, De Sutter P, et al.
J Mol Diagn
. 2023 Oct;
25(12):957-966.
PMID: 37865293
The VALHUDES protocol was established to evaluate clinical accuracy of human papillomavirus (HPV) assays to detect cervical precancer on first-void urine (FVU) and vaginal self-samples versus matched clinician-collected cervical samples...
5.
Latsuzbaia A, Broeck D, Van Keer S, Weyers S, Donders G, Doyen J, et al.
J Mol Diagn
. 2023 Jun;
25(9):702-708.
PMID: 37354994
The accuracy of high-risk human papillomavirus testing with the Xpert HPV assay on vaginal self-samples was compared with clinician-taken samples within the VALidation of HUman papillomavirus assays and collection DEvices...
6.
Latsuzbaia A, Broeck D, Van Keer S, Weyers S, Donders G, Doyen J, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Sep;
31(12):2177-2184.
PMID: 36099441
Background: In this study, we evaluated accuracy of HPV testing on self-samples versus clinician-taken samples through the VALHUDES protocol. VALHUDES was designed as a diagnostic test accuracy study, where women...
7.
Van Keer S, Latsuzbaia A, Broeck D, De Sutter P, Donders G, Doyen J, et al.
J Clin Virol
. 2022 Sep;
155:105271.
PMID: 36049283
Background: Urine collection is a non-invasive self-sampling method offering the prospect of reaching women un(der)-screened for cervical cancer. The VALHUDES research framework was designed to address the lack of clinical...
8.
Latsuzbaia A, Broeck D, Van Keer S, Weyers S, Tjalma W, Doyen J, et al.
Microbiol Spectr
. 2022 Sep;
10(5):e0163122.
PMID: 36047900
The VALHUDES framework (NCT03064087) was established to evaluate the clinical accuracy of HPV testing on self-samples compared with HPV testing on matched clinician-taken cervical samples. Women referred to colposcopy due...
9.
De Pauw H, Donders G, Weyers S, De Sutter P, Doyen J, Tjalma W, et al.
Arch Public Health
. 2021 Aug;
79(1):155.
PMID: 34462004
Background: Interventions to reach women who do not participate regularly in screening may reduce the risk of cervical cancer. Self-collection of a vaginal specimen has been shown to increase participation....
10.
Van Keer S, Peeters E, Broeck D, De Sutter P, Donders G, Doyen J, et al.
Gynecol Oncol
. 2021 Jun;
162(3):575-583.
PMID: 34172287
Objective: Urine self-sampling has gained increasing interest for cervical cancer screening. In contrast to analytical performance, little information is available regarding the clinical accuracy for high-risk Human Papillomavirus (hrHPV) testing...